Hydralazine. Hydralazine should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Hydralazine is classified as FDA pregnancy risk category C (Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women
Medications for high blood pressure during pregnancy Methyldopa Labetalol Nifedipine Hydralazine.
Intravenous Hydralazine and sodium Nitroprusside are no longer considered safe for use in pregnancy due to the risk of adverse perinatal events (Hydralazine)
Medications for high blood pressure during pregnancy Methyldopa Labetalol Nifedipine Hydralazine.
Cardiovascular Disease Medication During Pregnancy Beta-blockers can be used, and digoxin can be considered. During pregnancy, hydralazine
Hydralazine-HCTZ should only be given during pregnancy when benefit outweighs risk. In general, hydralazine has been used extensively and safely for the treatment of maternal hypertension during pregnancy.
Cardiovascular Disease Medication During Pregnancy Beta-blockers can be used, and digoxin can be considered. During pregnancy, hydralazine
Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in Pregnancy. NCT . 2024
Pregnancy and Breastfeeding - Hydralazine is a category C pregnancy drug and can cause adverse effects on the fetus. The drug passes into the
Comments
Great job 5 stars
PS You need to add pregnancy risk to your tags